Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 180

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Period 2 Mutation Accelerates ApcMin/+ Tumorigenesis

Open access
Wood, Patricia A., Yang, Xiaoming, Taber, Andrew, Oh, Eun-Young, Ansell, Christine, Ayers, Stacy E., Al-Assaad, Ziad, Carnevale, Kevin, Berger, Franklin G., Peña, Maria Marjorette O., Hrushesky, William J.M.·2008·Molecular Cancer Research

Published version of a preprint

Abstract

Colorectal cancer risk is increased in shift workers with presumed circadian disruption. Intestinal epithelial cell proliferation is gated throughout each day by the circadian clock. Period 2 (Per2) is a key circadian clock gene. Per2 mutant (Per2m/m) mice show an increase in lymphomas and deregulated expression of cyclin D and c-Myc genes that are key to proliferation control. We asked whether Per2 clock gene inactivation would accelerate intestinal and colonic tumorigenesis. The effects of PER2 on cell proliferation and β-catenin were studied in colon cancer cell lines by its down-regulation following RNA interference. The effects of Per2 inactivation in vivo on β-catenin and on intestinal and colonic polyp formation were studied in mice with Per2 mutation alone and in combination with an Apc mutation using polyp-prone ApcMin/+ mice. Down-regulation of PER2 in colon cell lines (HCT116 and SW480) increases β-catenin, cyclin D, and cell proliferation. Down-regulation of β-catenin along with Per2 blocks the increase in cyclin D and cell proliferation. Per2m/m mice develop colonic polyps and show an increase in small intestinal mucosa β-catenin and cyclin D protein levels compared with wild-type mice. ApcMin/+Per2m/m mice develop twice the number of small intestinal and colonic polyps, with more severe anemia and splenomegaly, compared with ApcMin/+ mice. These data suggest that Per2 gene product suppresses tumorigenesis in the small intestine and colon by down-regulation of β-catenin and β-catenin target genes, and this circadian core clock gene may represent a novel target for colorectal cancer prevention and control. (Mol Cancer Res 2008;6(11):1786–93)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1541-7786.mcr-08-0196

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 30

  1. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 2001;107:855–67. · DOI · Paper page
  2. You S, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky WJ. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat 2005;91:47–60. · DOI
  3. Wood PA, Du-Quiton J, You S, Hrushesky WJ. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther 2006;5:2023–33. · DOI
  4. Wood PA, Du-Quiton J, You S, Hrushesky WJM. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther 2006;5:2023–33. · DOI
  5. Bjarnason GA, Jordan RC, Wood PA, et al. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol 2001;158:1793–801. · DOI · Paper page
  6. Lincoln DW II, Hrushesky WJ, Wood PA. Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage. Int J Cancer 2000;88:479–85. · doi:10.1002/1097-0215(20001101)88:3<479::aid-ijc23>3.0.co;2-z
  7. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003;302:255–9. · DOI · Paper page
  8. Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem 2008;283:4535–42. · DOI · Paper page
  9. Buchi K, Moore J, Hrushesky W, Sothern R, Rubin N. Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology 1991;101:410–5. · DOI
  10. Neal JV, Potten CS. Circadian rhythms in the epithelial cells and the pericryptal fibroblast sheath in three different sites in the murine intestinal tract. Cell Tissue Kinet 1981;14:581–7. · DOI
  11. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41–50. · DOI · Paper page
  12. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268–74.
  13. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005;26:1241–6. · DOI · Paper page
  14. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003;95:825–8. · DOI · Paper page
  15. Viswanathan A, Hankinson S, Schernhammer ES. Night shift work and risk of endometrial cancer. Cancer Res 2007;67:10618–22. · DOI · Paper page
  16. Kolligs FT, Bommer G, Goke B. Wnt/β-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 2002;66:131–44. · DOI · Paper page
  17. Schneikert J, Behrens J. The canonical Wnt signaling pathway and its APC partner in colon cancer development. Gut 2007;56:417–25. · DOI · Paper page
  18. Karim R, Tse G, Putti T, Scolyer R, Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004;36:120–8. · DOI · Paper page
  19. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759–67. · DOI · Paper page
  20. You S, Ohmori M, Pena MM, et al. Developmental abnormalities in multiple proliferative tissues of ApcMin/+ mice. Int J Exp Pathol 2006;87:227–36. · DOI
  21. Yang M, Zhong WW, Srivastava N, et al. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway. Proc Natl Acad Sci U S A 2005;102:6027–32. · DOI · Paper page
  22. Reischl S, Vanselow K, Westermark PO, et al. β-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics. J Biol Rhythm 2007;22:375–86. · DOI · Paper page
  23. Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP. Transcriptional profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemias. Blood 2005;106:2827–36. · DOI · Paper page
  24. Hua H, Wang Y, Wan C, et al. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther 2007;14:815–8. · DOI
  25. Hua H, Wang Y, Wan C, et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 2006;97:589–96. · DOI · Paper page
  26. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler H. The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006;22:375–82. · DOI · Paper page
  27. Yeh KT, Yang MT, Liu TC, et al. Abnormal expression of Period I (PER I) in endometrial carcinoma. J Pathol 2005;206:111–20. · DOI
  28. Krugluger W, Brandstaetter A, Kallay E, et al. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res 2007;67:7917–22. · DOI
  29. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC−/− colon carcinoma. Science 1997;275:1784–7. · DOI · Paper page
  30. Tucker J, Davis CA, Kitchens M, et al. Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in ApcMin/+ mice. Cancer Lett 2002;187:153–62. · DOI

Cited by

See all 180

Metadata

Authors
Wood, P. A., Yang, X., Taber, A., Oh, E.-Y., Ansell, C., Ayers, S. E., Al-Assaad, Z., Carnevale, K., Berger, F. G., Peña, M. M. O., & Hrushesky, W. J. M.
Venue
Molecular Cancer Research
Published
2008-11-01
Volume
6
Issue
11
Pages
1786-1793
ISSN
  • 1541-7786 (ISSN-L)
  • 1557-3125
OpenAlex
W2102914417
Cited by
180
References
7
FWCI
4.46
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Period 2 Mutation Accelerates ApcMin/+ Tumorigenesis. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-08-0196
The paper
Wood, P. A., Yang, X., Taber, A., Oh, E.-Y., Ansell, C., Ayers, S. E., Al-Assaad, Z., Carnevale, K., Berger, F. G., Peña, M. M. O., & Hrushesky, W. J. M. (2008). Period 2 Mutation Accelerates ApcMin/+ Tumorigenesis. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-08-0196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.